FDA calls for withdrawal of weight loss drug Belviq after trials find cancer link squib

The US Food and Drug Administration has asked the maker of Belviq and Belviq XR to take the weight loss drugs off the market after clinical trials showed an increased incidence of cancer among users.
Scroll for more
Continue reading on CNN...